Human Neutrophil Cathepsin G: In Vivo Synthesis of Anti-HNCG Antibody, Inhibition of the Activity of HNCGs and Mechanism of the Inhibitions

사람 호중구 Cathepsin G: Anti-HNCG Ab의 In Vivo 합성, HNCG의 활성도 억제와 그 기전에 관한 연구

Human neutrophil cathepsin-G, which has been known as one of the active enzymes causing inflammatory diseases, was purified by two steps procedure involving one size exclusion (Ultorogel AcA54) and one ion exchange (CM-Sephadex) chromatography. Purified HNCGs were cross-reacted with Anti-HNCathepsin-G antibodies which were radised in rabbits and purified by cathepsin-G labeled Sepharose 4B affinity chromatography. HNCGs were effectively inhibited by NSAIDs including phenylbutazone, sulindac, oxyphenbutazone, salicylic acid and salicyluric acid. $IC_{50}_s$ of these drugs for inhibition of Cathepsin G were 0.3-0.8 mM. Other NSAIDs including aspirin showed little or no inhibition effect on the activity of Cathepsin G. These results strongly indicated that NSAIDs which showed inhibition effect on the activity of HNCGs possibly be at least a part of mechanism of action which might be related to direct inhibition of cathepsin G at the tissue destruction sites beside of their known mechanism of action as an anticyclo-oxygenase in treatment of inflammatory diseases. Lipid soluble component of Korean Red Ginseng which was known as an anti-inflammatory agent inhibited HNCGs strongly, but no other fractions did inhibited HNCGs. Antibiotics including novobiosin and rifamycin showed some inhibition effect on HNCGs, i. e.., $IC_{50}$ of these drugs were 2.6 mM and 1.5 mM respectively, and other antibiotics including penicillin G showed no or negligible inhibition effect on the activity of HNCGs. However. tetracyclines inhibited HNCGs very effectively at the concentration of therapeutic range. The inhibition effect of the activity of HNCGs by tetracycline are not related to the N-dimethyl radical on the 4 position of the tetracycline molecule. Furthermore, N-dedimethylated tetracyclines may have beneficial effect for long term treatment of chronic inflammatory diseases without developing any drug resistance to microorganisms.

염증성 질환의 원인 인자중 하나로 알려진 사람 호중구 Cathepsin G를 두단계의 크로마토그라피를 거쳐 분리하였다. 이 순수 분리된 효소를 이용하여 토끼에서 항체를 In Vivo 합성하고 그 혈액으로부터 순수 항체를 분리하였다. NSAIDs 약제중 phenylbutazone, sulindac, oxyphenbutazone, salicilic acid등은 이 효소를 강력하게 억제하였으며 $IC_{50}$은 $0.3{\sim}0.8\;mM$ 이었다. 고려인삼의 지용성분획도 tetracycline, novobiosin, rifamycin이 Cathepsin G의 효소 활성도에 대해서 강력한 억제 작용을 나타내었으나 다른 항생제는 그 작용이 무시할 수 있을 정도였다. 그러나 tetracycline계열의 항생제의 경우 실제 치료 효과를 나타내는 혈중농도에서 강한 억제 작용을 보였다. 특히 항균 작용과 관계하는 tetracycline의 4번 위치의 N-dimethy radical을 제거한 tetracycline은 감염군의 약제 저항성을 피할 수 있을 것으로 생각되므로 만성 염증성질환의 장기 치료에 이용될 수 있는 새로운 약제로써 제시한다.